Press release
Tremfya Drug Market Size to Reach USD 10.18 Billion by 2031 as Expanding Treatment Applications Support Market Growth
Tremfya Drug Market Overview
According to Mordor Intelligence, the tremfya drug market size [https://www.mordorintelligence.com/industry-reports/tremfya-drug-market?utm_source=abnewswire] is projected to grow from USD 6.43 billion in 2026 to USD 10.18 billion by 2031, registering a CAGR of 9.61% during the forecast period. The market growth is supported by expanding therapeutic applications, increasing adoption of targeted biologic treatments, and wider use across chronic inflammatory disease management.
The tremfya drug market continues to expand as healthcare providers increasingly use targeted therapies for conditions such as plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease. Tremfya's clinical position is supported by its targeted mechanism focused on IL-23 pathways, helping physicians manage immune-mediated conditions through advanced biologic treatment approaches.
The expansion of Tremfya beyond dermatology applications into gastroenterology has increased its role across multiple treatment areas. Growing recognition of biologics in chronic disease management and the need for long-term treatment options are supporting the tremfya drug market growth. Increased awareness among patients and healthcare professionals is also influencing adoption across developed and emerging healthcare systems.
Tremfya Drug Market Trends
Growing Use Across Multiple Chronic Conditions
The expansion of Tremfya into additional therapeutic areas is one of the major factors influencing the tremfya drug market trends. Initially associated with dermatology treatments, its use has expanded into inflammatory bowel disease care, supporting wider adoption among specialists.
Increasing Preference for Targeted Biologic Treatments
Biologic therapies are becoming an important part of treatment plans for immune-related disorders. Tremfya's focus on specific immune pathways provides healthcare professionals with another option for managing complex conditions where conventional treatments may not provide desired outcomes.
Expanding Treatment Delivery Options
Flexible administration methods are becoming increasingly important in chronic care management. The availability of different treatment delivery approaches supports patient convenience and helps reduce dependence on traditional healthcare settings.
Growing Focus on Specialty Healthcare Services
The demand for specialty medicines continues to increase as healthcare providers manage complex inflammatory diseases. Hospitals, specialty clinics, and pharmacies are strengthening their capabilities to support biologic treatment requirements.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/tremfya-drug-market?utm_source=abnewswire
Tremfya Drug Market Segmentation
By Application
*
Plaque Psoriasis
*
Psoriatic Arthritis
*
Ulcerative Colitis
*
Crohn's Disease
*
Other Applications
By Route of Administration
*
Subcutaneous Injection
*
Intravenous Infusion
By Distribution Channel
*
Hospital Pharmacies
*
Retail Pharmacies
*
Online Pharmacies
*
Other Distribution Channels
By Geography
*
North America
*
Europe
*
Asia-Pacific
*
Middle East and Africa
*
South America
Tremfya Drug Industry Key Player
The tremfya drug industry is led by Johnson & Johnson, which continues to focus on expanding clinical applications, strengthening treatment availability, and supporting healthcare providers managing chronic inflammatory diseases.
*
Johnson & Johnson
Conclusion
The tremfya drug market is expected to continue growing as demand increases for targeted biologic therapies across inflammatory disease treatment areas. Wider use in dermatology, rheumatology, and gastroenterology is strengthening its position within specialty healthcare.
The increasing focus on personalized treatment approaches and improved chronic disease management is creating steady opportunities across the market. Healthcare providers are adopting therapies designed to address specific disease pathways while supporting long-term patient care.
The future of the tremfya drug market forecast remains connected to expanding applications, physician adoption, and continued investment in specialty medicine. As biologic treatments become a greater part of healthcare strategies, the market is expected to maintain steady growth supported by increasing demand for advanced treatment options.
Industry Related Reports
Cough Syrup Market:
The cough syrup market is growing due to increasing prevalence of respiratory conditions, rising demand for over-the-counter cough treatments, and growing availability of combination medications. Expanding healthcare access and product developments targeting different age groups and cough types are further supporting market growth.
Get more insights: https://www.mordorintelligence.com/industry-reports/cough-syrup-market?utm_source=abnewswire
Heart Transplantation Therapeutic Market Size:
The heart transplantation therapeutic market is projected to grow from USD 1.44 billion in 2026 to USD 1.81 billion by 2031, registering a CAGR of 4.58% during 2026-2031. Growth is driven by increasing cases of advanced heart failure, improvements in transplant care, and advancements in immunosuppressive therapies.
Get more insights: https://www.mordorintelligence.com/industry-reports/heart-transplantation-therapeutics-market?utm_source=abnewswire
Actinium-225 Therapeutic Radioisotope Market Share:
The Actinium-225 therapeutic radioisotope market is projected to grow from USD 298.55 million in 2026 to USD 582.35 million by 2031, registering a CAGR of 14.30% during the forecast period. Rising adoption of targeted alpha therapies, increasing cancer research activities, and advancements in radiopharmaceutical development are driving market growth.
Get more insights: https://www.mordorintelligence.com/industry-reports/actinium-225-therapeutic-radioisotope-market?utm_source=abnewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=tremfya-drug-market-size-to-reach-usd-1018-billion-by-2031-as-expanding-treatment-applications-support-market-growth]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tremfya Drug Market Size to Reach USD 10.18 Billion by 2031 as Expanding Treatment Applications Support Market Growth here
News-ID: 4574361 • Views: …
More Releases from ABNewswire
Core advantages (compared to traditional fuel vehicles with water heating defros …
1. Compared to traditional engine water heating defrosting (fuel powered buses)
No engine dependency
Pure electric vehicles have no engine waste heat, and high-pressure defrosting is the only independent heating solution; The vehicle can defrost normally during idle, parking charging, and standby. In winter, the defrosting during parking at the station is not limited by engine start stop.
Extremely fast startup speed
Fuel powered cars need to heat up for 3-5 minutes before there…
5 Critical Factors Preventing Ear Tag Retention Failures in Commercial Cattle an …
Image: https://img.deepvaluer.com/i/XU6rK1
A missing Ear Tag is more than a minor equipment issue-it can break the data chain that supports herd inventory, disease traceability, export eligibility, and value-added marketing. In high-volume cattle and swine operations, even small retention losses can create measurable costs through replacement labor, chute time, compliance risk, and reduced animal performance after rehandling. This article examines the practical factors that determine whether livestock identification and traceability tags stay…
Beyond the Needle: How Automatic Continuous Syringes Are Revolutionizing Speed a …
Image: https://img.deepvaluer.com/i/f9yhMR
When a poultry house holds 50,000 to 100,000 birds, vaccination is no longer a routine handling task-it is a race against time, stress, and contamination risk. Automatic Continuous Syringes are changing that equation by replacing repeated manual reloading with consistent, closed-system dosing that supports faster flock processing and stronger biosecurity. For hatcheries, broiler operations, breeder farms, and integrated livestock producers, the right equipment can determine whether vaccines are delivered…
Is IP67 Enough, or Should Users Move from a Waterproof Micro Switch to a Sealed …
In equipment development, the occurrence of false triggering or failure even after selecting a IP67 waterproof micro switch [https://www.microswitchmanufacturer.com/waterproof-micro-switch/] often stems from a mismatch between the protection level and the actual environment. IP67 is typically only applicable to short-term water contact and is not suitable for continuous moisture, temperature condensation, or contaminated environments. Whether to continue using IP67 or upgrade to a sealed or higher protection solution for complex operating…
More Releases for Tremfya
In-Depth Examination of Segments, Industry Patterns, and Key Competitors in the …
The Tremfya market is set to experience notable growth over the coming years, driven by several key factors shaping the demand for innovative treatments in inflammatory diseases. Let's explore the current market outlook, leading players, emerging trends, and segmentation details to understand this sector's future trajectory.
Forecasted Growth and Expansion Drivers in the Tremfya Market
The projected expansion of the Tremfya market through 2030 is largely fueled by the rising…
Tremfya Industry Report 2025-2034: Market Dynamics, Drivers, And Forecasts
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Tremfya Market?
In more recent times, the market size for Tremfya has experienced a growth of XX (HCAGR). There is an expected increase from $XX million in 2024 to $XX million in 2025, reflecting a compound annual growth rate (CAGR) of XX%. Factors that have…
Tremfya Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emer …
What combination of drivers is leading to accelerated growth in the tremfya market?
The increasing prevalence of autoimmune diseases is expected to propel the growth of the Tremfya market going forward. Autoimmune diseases refer to conditions in which the body's immune system mistakenly attacks its cells, tissues, or organs, perceiving them as foreign invaders. The increasing prevalence of autoimmune diseases is due to genetic predisposition, environmental triggers, lifestyle changes, increased awareness,…
Tremfya Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emer …
What combination of drivers is leading to accelerated growth in the tremfya market?
The increasing prevalence of autoimmune diseases is expected to propel the growth of the Tremfya market going forward. Autoimmune diseases refer to conditions in which the body's immune system mistakenly attacks its cells, tissues, or organs, perceiving them as foreign invaders. The increasing prevalence of autoimmune diseases is due to genetic predisposition, environmental triggers, lifestyle changes, increased awareness,…
Ulcerative Colitis Clinical Pipeline | 70+ Companies Pioneering the Next Breakth …
The ulcerative colitis market is undergoing a transformative shift, driven by cutting-edge research and innovative therapies.
DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Ulcerative Colitis therapies in various stages of clinical development. Major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Ulcerative Colitis pipeline domain.
For Ulcerative Colitis emerging drugs, the Ulcerative Colitis pipeline analysis report provides a…
Giant-Cell Arteritis Market to witness growth by 2034, estimates DelveInsight | …
Giant-Cell Arteritis companies are AbbVie, CSL, Kiniksa Pharmaceuticals, Dr Reddys Laboratories, Eli Lilly and Company, Janssen Biotech, Johnson & Johnson, Kiniksa Pharmaceuticals, Ltd., MorphoSys AG, Novartis Pharmaceuticals, Roche Holding, XOMA, and several others.
(Albany, USA) DelveInsight's "Giant-Cell Arteritis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Giant-Cell Arteritis, historical and forecasted epidemiology as well as the Giant-Cell Arteritis market trends in the United States, EU5 (Germany, Spain,…
